A New Model for Breast Cancer Care: Detect, Diagnose & Cure in One Visit
AI-powered ultrasound finds cancer in all breast densities within minutes. No pain, no radiation, no wasted time. This process occurs at the point of need (PON) where women care for their families, work, and live.
AI guided biopsy collects a sample, followed by a rapid molecular diagnostic test delivering results within hours, delivering a clear yes-or-no answer like a pregnancy test, and identifies the tumor’s genetic profile, guiding targeted treatment options.
AI technology guides to the known cancer location, and the tumor is treated immediately with cryoablation, a minimally invasive procedure that freezes and destroys cancer cells, while triggering an immune response.
Curing Women’s Cancer (CWC) is transforming breast cancer care with a breakthrough three-step solution that detects, diagnoses, and cures cancer in a single visit at point of need (PON) — and that too in just six hours. Built on decades of research, this model turns proven methods into one seamless, life-saving protocol.
By reducing delays, improving access, and increasing survival rates, this approach could change outcomes for the 2.5 billion women worldwide who currently lack timely breast cancer care, especially in poor and remote communities.
Now, we need your help to bring it to life.
Your support will fund vital clinical trials and accelerate a new model for breast cancer care.
Together, we can save more lives.
We’re changing the way breast cancer is detected, diagnosed and treated for a faster, smarter, and more accessible solution.






Breast cancer is the leading cause of cancer deaths in women globally. Yet, many of these deaths are largely avoidable. By making early detection, diagnosis, and treatment faster, simpler, and more accessible, we are closing the gap and giving more women the chance to survive and thrive.
Watch this video to hear Co-founder Dr. Susan Harvey, a leading expert in breast cancer innovation, explain how this breakthrough will save lives.
women worldwide lack access to breast cancer care.
In wealthier nations, the five-year survival rate is 98.6% — nearly every woman diagnosed has a fighting chance.
But access to care is far from universal.
Even in high-income countries, millions still struggle to get timely screening and treatment due to cost, location, or systemic barriers. For example, in the U.S., Black women are 42% more likely to die from breast cancer than white women.
In lower-income regions, the disparities are even more devastating.
In South Africa, the five-year survival rate drops to just 40%.
The reality is clear: survival should not depend on where a woman lives, or the color of her skin.
CWC exists to change this.
We are raising funds for clinical studies to bring this life-saving care model to communities that need it most.
These studies will prove the success of the CWC solution to detect, diagnose and cure breast cancer at the PON for widespread adoption and use.
In partnership with trusted, locally established organizations, our clinical trials are community-led, culturally appropriate, and aligned with local healthcare needs, delivering last-mile care by reaching underserved communities.
8 Sep - Standard
Phasellus enim libero, blandit vel sapien vitae, condimentum ultricies magna et. Quisque euismod orci utet.
READ MORE8 Sep - Standard
Phasellus enim libero, blandit vel sapien vitae, condimentum ultricies magna et. Quisque euismod orci utet.
READ MORE8 Sep - Standard
Phasellus enim libero, blandit vel sapien vitae, condimentum ultricies magna et. Quisque euismod orci utet.
READ MORE8 Sep - Standard
Phasellus enim libero, blandit vel sapien vitae, condimentum ultricies magna et. Quisque euismod orci utet.
READ MORECWC is led by world-renowned breast cancer experts, bringing together a diverse group of researchers, clinicians, advocates, patients, and industry leaders who are committed to revolutionizing breast cancer care.

Raj and Kamla Gupta, Professor of Infectious Diseases at Johns Hopkins University School of Medicine, Expert in HIV. He has worked in India and Uganda for decades and continues his work at JHU and globally.

A global financial expert with a focus on equity, he has led a successful purpose-driven investment opportunities firm.

Lee Kosmac is an experienced business leader, enlightened entrepreneur and forward-thinking investor determined to make a difference in the world. She promotes narrative dialogue integrated with cutting edge technology to influence change and capitalize opportunity.

Michael has expertise in manufacturing consulting, security, and crisis management and has started and sold several companies. Michael brings business skills to the team.

Clinical expert in breast imaging, practicing for 30 years. Led breast imaging at Johns Hopkins for eight years, expanding from 2 to 8 sites, building an education program, research, and grant funding capabilities. Worked at Hologic Inc. as VP of Medical Affairs and lived commercialization.
CWC is a registered 501(c)(3), non-profit organization and your support may be tax-deductible. Join us in changing the future of breast cancer.
Contact us to learn more, support a trial, or get involved.
© CWC 2025. All Rights Reserved.